APC Implantable Pacing Lead, Tined #3262
510(k) K810396
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK810396 | Date15 May 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The APC Implantable Pacing Lead, Tined #3262 is a permanent pacemaker electrode designed for cardiac pacing applications. It delivers electrical impulses to stimulate the heart muscle, ensuring proper heart rhythm in patients with bradycardia or conduction disorders. The tined design enhances fixation within the cardiac chamber, providing stable lead positioning.
This lead is supplied sterile and intended for single-use implantation during surgical procedures. It is classified as a Class III medical device under FDA regulations and requires compliance with 21 CFR Part 870.3680. The device is intended for use in cardiac electrophysiology settings and must be handled under aseptic conditions. Authorized by FDA 510(k) clearance (K810396), it adheres to traditional review pathways and is distributed for use in cardiovascular applications.
Other devices from American Pacemaker Corp.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the APC Implantable Pacing Lead, Tined #3262, and how does its design support its function?
The APC Implantable Pacing Lead, Tined #3262 is designed to deliver electrical impulses to the heart muscle, helping maintain proper heart rhythm in patients with bradycardia or conduction disorders. The tined design enhances fixation within the cardiac chamber, ensuring stable lead positioning during and after implantation. This stability is critical for reliable pacing performance over time.
Is this device intended for reuse, or is it meant for single-use only? How should it be handled before implantation?
This device is supplied sterile and intended for single-use only during surgical procedures. Due to its sterile packaging and classification as a Class III medical device, it must be handled under aseptic conditions to prevent contamination before implantation. Reuse is not recommended or supported by the manufacturer.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its use in clinical settings?
The APC Implantable Pacing Lead, Tined #3262 was cleared via the FDA 510(k) pathway, specifically under Traditional Review by the Cardiovascular (CV) Advisory Committee. This means the device was determined to be substantially equivalent to a legally marketed predicate device, ensuring it meets FDA safety and effectiveness standards for use in cardiac electrophysiology settings. Clinicians can rely on this clearance as evidence of regulatory scrutiny before implementation.
Where is this device manufactured, and what address should be referenced for regulatory or distribution inquiries?
The device is manufactured by American Pacemaker Corp. at their facility located at 803 N. Front St. Suite 3, Mchenry, IL 60050. This address is relevant for regulatory inquiries, distribution requests, or compliance-related communications, as it is the official address listed in the FDA submission records.
How does the tined design of this lead differ from other pacing leads, and what clinical benefits does it provide?
The tined design of the APC Implantable Pacing Lead, Tined #3262 features small, flexible protrusions at the distal end that anchor the lead to the cardiac chamber wall. This contrasts with smooth-tip leads, which rely on passive fixation or passive fixation tines. The tined design provides enhanced stability and reduced risk of dislodgment, which is particularly beneficial for patients with irregular heart rhythms or those requiring long-term pacing support. This stability ensures consistent electrical stimulation and reduces the need for frequent lead adjustments.